Phase 2 Study to Assess the Safety and Efficacy of ANG003

Abroad (travel likely)RecruitingPHASE2

Conditions

Exocrine Pancreatic Insufficiency (EPI) · Cystic Fibrosis (CF)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Long Beach Memorial Medical Center, Long Beach, California, United States
Contact: Study coordinator (Angelica Rodriguez) · ARodriguez9@memorialcare.org · 562-706-1245
Center for Cystic Fibrosis at Keck Medical Center of USC, Los Angeles, California, United States
Contact: Study coordinator (Lynn Fukushima) · lynn.fukushima@med.usc.edu · 323-442-8522
National Jewish Health, Denver, Colorado, United States
Contact: Study coordinator (Alix Wilson) · wilsona@njhealth.org · 303-270-2517
University of Florida, Gainesville, Florida, United States
Contact: Study coordinator (Alexa Smith) · alexa.howell@ufl.edu · 352-273-8380
Central Florida Pulmonary Group, Orlando, Florida, United States
Contact: Study coordinator (Desiree Serr) · desiree.serr1@adventhealth.com · 407-303-7192
The Cystic Fibrosis Institute, Glenview, Illinois, United States
Contact: Study coordinator (Steven R Boas, MD) · sboas@wecare4lungs.com · 847-998-3434
University of Iowa, Iowa City, Iowa, United States
Contact: Study coordinator (Mary Teresi) · mary-teresi@uiowa.edu · 319-384-7546
University of Kansas Medical Center, Kansas City, Kansas, United States
Contact: Study coordinator (Lawrence Scott) · lscott2@kumc.edu · 913-588-4020
University of Kentucky, Lexington, Kentucky, United States
Contact: Study coordinator (Chase Whitaker) · chase.whitaker@uky.edu · 859-218-4810
MaineHealth Pediatric Specialty Care, Portland, Maine, United States
Contact: Study coordinator (Rebecca Edwards) · rebecca.edwards@mainehealth.org · 207-662-6712
Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Margot Hardcastle) · mhardcastle@mgh.harvard.edu · 617-726-3719
Boston Children's Hospita, Boston, Massachusetts, United States
Contact: Study coordinator (Robert Fowler) · Robert.fowler@childrens.harvard.edu · 617-355-1834
University of Michigan, Michigan Medicine, Ann Arbor, Michigan, United States
Contact: Study coordinator (Dawn Kruse) · dmkruse@med.umich.edu · 734-615-3266
Wayne State University Harper University Hospital, Detroit, Michigan, United States
Contact: Study coordinator (Debra Driscoll) · ddriscol@med.wayne.edu · 313-745-2221
Rutgers - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
Contact: Study coordinator (Sheila Redding) · sr1238@rwjms.rutgers.edu · 732-235-7840
New York Medical College at Westchester Medical Center, Valhalla, New York, United States
Contact: Study coordinator (Zachary Messer) · Zachary_Messer@nymc.edu · 914-594-2352
Children's Hospital Medical Center of Akron, Akron, Ohio, United States
Contact: Study coordinator (Michelle Parrish) · MParrish@akronchildrens.org · 330-543-3089
Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Contact: Study coordinator (Primary RC & Participant Contact General Contact) · RainbowCFResearch@UHhospitals.org · 216-844-3911
Nationwide Children's Hospital, Columbus, Columbus, Ohio, United States
Contact: Study coordinator (Diana Gilmore) · diana.gilmore@nationwidechildrens.org · 614-722-4752
Toledo Children's Hospital, Toledo, Ohio, United States
Contact: Study coordinator (Kelly Hoot) · kelly.hoot@promedica.org · 419-291-4630
Hershey Medical Center Pennsylvania State University, Hershey, Pennsylvania, United States
Contact: Study coordinator (Diane Kitch) · dkitch@pennstatehealth.psu.edu · 717-531-5646
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Adrienne DeRicco) · adrienne.dericco2@upmc.edu · 412-692-8069
University of Texas Southwestern / Children's Health, Dallas, Texas, United States
Contact: Study coordinator (Keianna Brown) · Keianna.brown@utsouthwestern.edu · 214-456-5489
Adult Cystic Fibrosis Center at the University of Utah, Salt Lake City, Utah, United States
Contact: Study coordinator (Kristyn Packer) · kristyn.packer@hsc.utah.edu · 801-520-5106
University of Wisconsin, Madison, Wisconsin, United States
Contact: Study coordinator (Melanie Nelson) · mnelson@pediatrics.wisc.edu · 608-265-4617
Froedtert & Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Study coordinator (Erin Hubertz) · ehubertz@mcw.edu · 414-955-7019

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

Cystic Fibrosis · Pancreatic Insufficiency · Abnormal Glucose Tolerance

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Philadelphia, United States

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

Cystic Fibrosis · Pancreatic Insufficiency

Abroad (travel likely)Recruiting

Philadelphia, United States

Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients

Exocrine Pancreatic Insufficiency (EPI) · Pancreatitis

Abroad (travel likely)RecruitingPHASE3

Boston, United States

Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis

Pancreatic Insufficiency · Cystic Fibrosis-related Diabetes

Abroad (travel likely)RecruitingPHASE1

Philadelphia, United States · Philadelphia, United States